Swiss Parliament Rejects Proposal to Ban Tobacco Advertisements

Regulations by 2FIRSTS.ai

Mar.05.2024

Swiss Parliament Rejects Proposal to Ban Tobacco Advertisements

Swiss Parliament rejects proposal to ban tobacco and e-cigarette ads, sparking debate among political parties. Future uncertain.

According to persoenlich report, the Swiss parliament rejected the proposal for a ban on tobacco advertising aimed at children and adolescents, with a vote of 121 to 64 (5 abstentions). The proposal sought to completely ban the advertising of tobacco products and e-cigarettes, and had received majority support from voters in a national referendum in February 2022.

Currently, the proposal is set to be sent back to the Senate. If the Senate rejects it again or if the House of Representatives opposes it a second time, the proposal will come to an end. At that point, Parliament will need to come up with a new plan to implement the new constitutional provisions.

According to reports, there is a clear division among political parties regarding the vote on the proposal. The Swiss People's Party (SVP) criticizes the Federal Council's draft for exceeding the scope of the original proposal, believing that the law would be unenforceable and unreasonable in practice. On the other hand, the Social Democrats (SP) and the Green Party are trying to push for strict enforcement of the proposal to achieve a complete ban on tobacco advertising. They argue that the current parliamentary decision ignores the will of the people.

In such a division, the proposal ultimately faced rejection in the legislature.

References:

[1] Tabakwerbeverbot: Nationalrat lehnt Vorlage zur Umsetzung ab

Also Read:

[1] Altria Group's Stock Rating Revised with Lower Target Price

[2] UBS Downgrades BAT Rating to "Neutral" in Recent Report

[3] Continued Allowance of Tobacco Advertising in Swiss Print Media

[4] JTI Appoints New Factory Manager in Switzerland

#Europe #Traditional tobacco #Legislation #Regulation #Switzerland #European Parliament

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn

Notice

1. This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2. The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3. This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4. Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

Copyright

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

AI Assistance Disclaimer

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

U.S FDA Announces Dec. 8 Deadline for IQOS MRTP Renewal Comments

The U.S. FDA has set December 8, 2025, 11:59 p.m. ET as the closing date for public comments on the MRTP renewal applications submitted by Philip Morris Products S.A. for several IQOS heated tobacco products.

Nov.07 by 2FIRSTS.ai

Imperial Brands FY25 Results: NGP Net Revenue Up 13.7%, Americas Surges Nearly 70%

Imperial Brands reported FY25 NGP net revenue of £368 million, up 13.7% at constant currency. Growth in the Americas accelerated sharply, with NGP revenue up 69.8%, driven by the expansion of the modern oral brand Zone. Europe delivered 8.8% growth, supported by blu’s double-digit vapour share across key markets. Adjusted NGP operating losses narrowed to £76 million, putting the category closer to breakeven.

Nov.18 by 2FIRSTS.ai

FDA CTP Acting Director Supports Expanding Authorized Flavored E-Cigs and Legal Marketplace

At the FDLI Tobacco and Nicotine Policy Conference, FDA CTP Acting Director Bret Koplow spoke in favor of promoting tobacco harm reduction to reduce smoking. He backed a legal marketplace for authorized reduced-risk products, potential expansion of flavored e-cigs, and faster FDA reviews to ensure a strong, regulated market.

Oct.29 by 2FIRSTS.ai

NSW Landlords Could Face Jail or $165,000 Fine for Allowing Illegal Vape and Tobacco Sales

According to The Guardian, landlords in New South Wales who knowingly allow tenants to sell illicit tobacco or illegal vapes could face fines of up to AUD 165,000, a year in prison, or both. The new offences are part of the state government’s broader crackdown on Australia’s growing black market for cigarettes and vaping products.